These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18023093)

  • 41. Transarterial chemoembolization in unresectable hepatocellular carcinoma--assessing the factors affecting the survival: An audit from a tertiary care center in northern India.
    Agarwal A; Yadav AK; Kumar A; Gupta S; Panwala HK; Redhu N; Hariprasad S; Ranjan P; Arora A; Gupta A
    Indian J Gastroenterol; 2015 Mar; 34(2):117-26. PubMed ID: 25937484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.
    Llovet JM; Bustamante J; Castells A; Vilana R; Ayuso Mdel C; Sala M; Brú C; Rodés J; Bruix J
    Hepatology; 1999 Jan; 29(1):62-7. PubMed ID: 9862851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy.
    Lin ZZ; Hsu C; Hu FC; Shao YY; Chang DY; Yang CH; Hong RL; Hsu CH; Cheng AL
    Oncologist; 2012; 17(7):970-7. PubMed ID: 22673633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors influencing the short-term and long-term survival of hepatocellular carcinoma patients with portal vein tumor thrombosis who underwent chemoembolization.
    Chen KL; Gao J
    World J Gastroenterol; 2021 Apr; 27(13):1330-1340. PubMed ID: 33833486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The CRP level and STATE score predict survival in cirrhotic patients with hepatocellular carcinoma treated by transarterial embolization.
    Rekik S; Guyot E; Bhais M; Ajavon Y; Grando V; Bourcier V; Nkontchou G; Nahon P; Sellier N; Seror O; Ganne-Carrie N; Nault JC
    Dig Liver Dis; 2016 Sep; 48(9):1088-92. PubMed ID: 27375209
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcatheter arterial embolization for hepatocellular carcinoma with portal vein thrombosis.
    Yen FS; Wu JC; Kuo BI; Chiang JH; Chen TZ; Lee SD
    J Gastroenterol Hepatol; 1995; 10(3):237-40. PubMed ID: 7548796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort.
    Adhoute X; Pénaranda G; Raoul JL; Edeline J; Blanc JF; Pol B; Campanile M; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Le Treut YP; Bronowicki JP; Bourlière M
    World J Gastroenterol; 2017 Apr; 23(14):2545-2555. PubMed ID: 28465639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome and prognostic factors of spontaneous ruptured hepatocellular carcinoma treated with transarterial embolization.
    Shin BS; Park MH; Jeon GS
    Acta Radiol; 2011 Apr; 52(3):331-5. PubMed ID: 21498371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Modified CLIP score as a new prognostic index for patients with hepatocellular carcinoma].
    Han SH; Han SY; Go BS; Kim MJ; Lee JH; Koo YH; Ryu SH; Cho JH; Jang JS; Lee JH; Roh MH; Choi SR; Choi JC; Lee SW
    Korean J Hepatol; 2006 Jun; 12(2):209-20. PubMed ID: 16804346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis.
    Nouso K; Ito Y; Kuwaki K; Kobayashi Y; Nakamura S; Ohashi Y; Yamamoto K
    Br J Cancer; 2008 Apr; 98(7):1161-5. PubMed ID: 18349849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
    N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
    Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
    Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y
    Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
    Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening.
    Tseng PL; Wang JH; Tung HD; Hung CH; Kee KM; Chen CH; Chang KC; Lee CM; Changchien CS; Chen PF; Tsai LS; Lu SN
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1426-34. PubMed ID: 20659234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of serum gamma-glutamyl transferase in patients with intermediate hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
    Zhang JB; Chen Y; Zhang B; Xie X; Zhang L; Ge N; Ren Z; Ye SL
    Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):787-93. PubMed ID: 21730869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis.
    Denys A; Lacombe C; Schneider F; Madoff DC; Doenz F; Qanadli SD; Halkic N; Sauvanet A; Vilgrain V; Schnyder P
    J Vasc Interv Radiol; 2005 Dec; 16(12):1667-74. PubMed ID: 16371534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
    Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ
    Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.